MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
|
Back to Search Results |
|
Model Number 97800 |
Device Problems
Electromagnetic Interference (1194); Loss of Data (2903)
|
Patient Problems
Urinary Frequency (2275); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/16/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stim.The reason for call was that the patient reports that they had an mri today and after the mri was over, they went to turn the therapy back on and when they pulled up the therapy screen, number that was on the therapy screen was gone.The caller asked if they were on the wrong program.Reviewed mri mode deactivation steps and that the therapy resumes at the previous settings.The caller indicates that it did not.The caller asked how this may have happened.Reviewed perhaps interrupted telemetry.The caller was able to turn the device back on to desired settings.The caller will maintain stimulation level and will continue to track symptoms.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the patient.They reported that to resolve the issue on (b)(6) a nurse at the hospital (the patient has a pacemaker) answered questions and called support to verify all was reset properly.The issue was resolved.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the patient.The patient said that they had to turn their therapy off for the mri and the medtronic representative, was controlling their therapy with their programmer.The representative turned the stimulation up really high and the patient did not enjoy having the rep control their settings.Since then the patient has increased their stimulation to 5.0ma and close to 6.0ma and they are notfeeling stim or getting any relief at night.Patient said they have been getting up at least 4 times at night and each week since the mri, their symptoms have gotten worse and worse.Patient said their symptoms are back to what they started with before the ins.Patient wanted to know if the rep's programmer was able to control their therapy settings/damage their ins.Patient services specialist reviewed role of rep programmer vs patient's programmer.Reviewed what could happen if s tim is too high.Reviewed general therapy guidelines and therapy optimization options.Patient said they'd like to try a new program.Patient connected to ins on the call and changed programs and when increasing, they could not feel stim.Patient wanted to try going back to their original program and when they increased stim, they started to feel a tingling and it was comfortable.Patient said they will stay with their current program and monitor symptoms.Ps suggested making an appt with the hcp to check circuitry.Patient also mentioned they have a pet scan scheduled in two weeks.Reviewed guidelines.
|
|
Search Alerts/Recalls
|
|
|